Drug General Information
Drug ID
D09ELP
Former ID
DNAP001691
Drug Name
Clevidipine butyrate
Synonyms
Cleviprex (TN)
Drug Type
Small molecular drug
Indication Hypertension [ICD9: 401; ICD10:I10-I16] Approved [529941], [530865]
Company
The Medicines Company
Structure
Download
2D MOL

3D MOL

Formula
C21H23Cl2NO6
Canonical SMILES
CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)O<br />C)C)C
InChI
1S/C21H23Cl2NO6/c1-5-7-15(25)29-10-30-21(27)17-12(3)24-11(2)16(20(26)28-4)18(17)13-8-6-9-14(22)19(13)23/h6,8-9,18,24H,5,7,10H2,1-4H3/t18-/m1/s1
InChIKey
KPBZROQVTHLCDU-GOSISDBHSA-N
CAS Number
CAS 166432-28-6
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Calcium channel Target Info Modulator [529941], [530865]
References
Ref 5299412008 FDA drug approvals. Nat Rev Drug Discov. 2009 Feb;8(2):93-6.
Ref 530865Clevidipine: a short-acting intravenous dihydropyridine calcium channel blocker for the management of hypertension. Pharmacotherapy. 2010 May;30(5):515-28.
Ref 5299412008 FDA drug approvals. Nat Rev Drug Discov. 2009 Feb;8(2):93-6.
Ref 530865Clevidipine: a short-acting intravenous dihydropyridine calcium channel blocker for the management of hypertension. Pharmacotherapy. 2010 May;30(5):515-28.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.